Read + Share
Amedeo Smart
Independent Medical Education
Tankou J, Ruau S, Walia A, Toboni M, et al. AXL inhibition improves the therapeutic efficacy of trastuzumab in high-risk endometrial cancer. Gynecol Oncol 2025;204:52-62.PMID: 41270342
Email
LinkedIn
Privacy Policy